APP and Alzheimer disease: We next crossed GKO mice with the J20 AD mouse model (expressing human APP bearing the Swedish and Indiana mutations under the human platelet-derived growth factor beta polypeptide [PDGFB] promoter; Mucke et al., 2000) to investigate effects of GSAP deletion on AD-associated molecular and behavior changes in vivo.